Pediatric cancer recurrence remains a daunting challenge for families and medical professionals alike, often signaling a tough battle ahead for young patients.A groundbreaking study at Mass General Brigham has unveiled an innovative AI tool that promises to enhance predictions regarding the risk of relapse among children diagnosed with brain tumors, specifically gliomas.